back conversion test [Regulatives / Guidelines]

posted by Thair Saleh – Jordan, 2024-07-01 11:42 (716 d 23:21 ago) – Posting: # 24050
Views: 2,666

dear Colleagues


in the case of metabolites, (unstable N-oxides or glucuronide metabolites, lactone-ring structures) found in the drug should always covered by the back conversion test, or there is a limit (2%, 5%, 10%) of the drug if the metabolite exceeds then should be covered.

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
153 visitors (0 registered, 153 guests [including 12 identified bots]).
Forum time: 11:03 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5